Repositioning Candidates
Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
inflammatory457 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R1501 | DB13915 | approved | biotech | Axicabtagene ciloleucel | Therapeutic strategy associated | Details |
| R1506 | DB13973 | approved; investigational | biotech | Remestemcel-L | Therapeutic strategy associated | Details |
| R1507 | DB13975 | experimental | biotech | Black cohosh | Therapeutic strategy associated | Details |
| R1511 | DB14004 | approved; investigational | biotech | Tildrakizumab | Therapeutic strategy associated | Details |
| R1512 | DB14006 | approved; nutraceutical | small molecule | Choline salicylate | Therapeutic strategy associated | Details |
| R1517 | DB14059 | experimental; investigational | small molecule | SC-236 | Therapeutic strategy associated | Details |
| R1518 | DB14487 | approved; investigational | small molecule | Zinc acetate | Therapeutic strategy associated | Details |
| R1522 | DB14512 | approved; investigational; vet_approved | small molecule | Mometasone furoate | Therapeutic strategy associated | Details |
| R1525 | DB14538 | experimental; vet_approved | small molecule | Hydrocortisone aceponate | Therapeutic strategy associated | Details |
| R1526 | DB14539 | approved; vet_approved | small molecule | Hydrocortisone acetate | Therapeutic strategy associated | Details |
| R1527 | DB14540 | approved; vet_approved | small molecule | Hydrocortisone butyrate | Therapeutic strategy associated | Details |
| R1528 | DB14541 | approved; investigational; vet_approved | small molecule | Hydrocortisone cypionate | Therapeutic strategy associated | Details |
| R1529 | DB14542 | approved; vet_approved | small molecule | Hydrocortisone phosphate | Therapeutic strategy associated | Details |
| R1530 | DB14543 | approved; vet_approved | small molecule | Hydrocortisone probutate | Therapeutic strategy associated | Details |
| R1531 | DB14544 | approved; vet_approved | small molecule | Hydrocortisone valerate | Therapeutic strategy associated | Details |
| R1533 | DB14597 | approved; investigational | biotech | Lanadelumab | Therapeutic strategy associated | Details |
| R1534 | DB14631 | approved; vet_approved | small molecule | Prednisolone phosphate | Therapeutic strategy associated | Details |
| R1535 | DB14635 | experimental | small molecule | Curcumin sulfate | Therapeutic strategy associated | Details |
| R1536 | DB14644 | approved | small molecule | Methylprednisolone hemisuccinate | Therapeutic strategy associated | Details |
| R1537 | DB14669 | approved; vet_approved | small molecule | Betamethasone phosphate | Therapeutic strategy associated | Details |
| R1538 | DB14683 | experimental | small molecule | Prezatide copper | Therapeutic strategy associated | Details |
| R1540 | DB14731 | approved; investigational | biotech | Tagraxofusp | Therapeutic strategy associated | Details |
| R1542 | DB14762 | approved; investigational | biotech | Risankizumab | Therapeutic strategy associated | Details |
| R1545 | DB14845 | approved; investigational | small molecule | Filgotinib | Therapeutic strategy associated | Details |
| R1550 | DB14999 | approved; investigational | biotech | Human interferon beta | Therapeutic strategy associated | Details |
| R1551 | DB15011 | approved; investigational | small molecule | Avacopan | Therapeutic strategy associated | Details |
| R1554 | DB15090 | approved; investigational | biotech | Tezepelumab | Therapeutic strategy associated | Details |
| R1555 | DB15091 | approved; investigational | small molecule | Upadacitinib | Therapeutic strategy associated | Details |
| R1565 | DB15566 | approved; vet_approved | small molecule | Prednisolone acetate | Therapeutic strategy associated | Details |
| R1566 | DB15595 | approved | biotech | Ebola Zaire vaccine (live, attenuated) | Therapeutic strategy associated | Details |
| R1567 | DB15598 | approved | small molecule | Ferric maltol | Therapeutic strategy associated | Details |
| R1572 | DB15724 | investigational | biotech | Human umbilical cord blood mononuclear cell-conditioned medium | Therapeutic strategy associated | Details |
| R1574 | DB15729 | investigational | biotech | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | Therapeutic strategy associated | Details |
| R1576 | DB15731 | investigational | biotech | Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells | Therapeutic strategy associated | Details |
| R1577 | DB15742 | investigational | biotech | MultiStem | Therapeutic strategy associated | Details |
| R1579 | DB15746 | investigational | biotech | Recombinant Human Plasma Gelsolin | Therapeutic strategy associated | Details |
| R1580 | DB15750 | investigational | biotech | Trefoil Factor 2 | Therapeutic strategy associated | Details |
| R1581 | DB15751 | investigational | biotech | MRx-4DP0004 | Therapeutic strategy associated | Details |
| R1582 | DB15753 | investigational | biotech | Interferon Gamma | Therapeutic strategy associated | Details |
| R1583 | DB15762 | approved | biotech | Satralizumab | Therapeutic strategy associated | Details |
| R1584 | DB15866 | investigational | biotech | CK0802 | Therapeutic strategy associated | Details |
| R1586 | DB15869 | investigational | biotech | Platelet Lysate | Therapeutic strategy associated | Details |
| R1587 | DB15890 | investigational | biotech | RAPA-501-Allo | Therapeutic strategy associated | Details |
| R1589 | DB16157 | investigational | small molecule | Ensifentrine | Therapeutic strategy associated | Details |
| R1590 | DB16165 | approved; investigational | small molecule | Finerenone | Therapeutic strategy associated | Details |
| R1591 | DB16247 | investigational | biotech | Nangibotide | Therapeutic strategy associated | Details |
| R1593 | DB16366 | investigational | biotech | F-652 | Therapeutic strategy associated | Details |
| R1594 | DB16367 | approved; investigational | biotech | Autologous peripheral blood-derived CD34+ cells | Therapeutic strategy associated | Details |
| R1595 | DB16398 | investigational | biotech | Efmarodocokin alfa | Therapeutic strategy associated | Details |
| R1596 | DB16416 | investigational | biotech | Vilobelimab | Therapeutic strategy associated | Details |
| R1597 | DB16447 | investigational | small molecule | Thymoquinone | Therapeutic strategy associated | Details |
| R1598 | DB16448 | investigational | biotech | CD24Fc | Therapeutic strategy associated | Details |
| R1599 | DB16452 | investigational | small molecule | MAS825 | Therapeutic strategy associated | Details |
| R1600 | DB16522 | investigational | small molecule | Sodium copper chlorophyllin | Therapeutic strategy associated | Details |
| R1601 | DB16620 | investigational | small molecule | Methopterin | Therapeutic strategy associated | Details |
| R1604 | DB16648 | approved | biotech | Bacillus calmette-guerin substrain russian BCG-I live antigen | Therapeutic strategy associated | Details |
| R1608 | DB16703 | approved; investigational | small molecule | Belumosudil | Therapeutic strategy associated | Details |